Spine
-
Clinical prospective cohort study in academic tertiary setting. ⋯ No significant changes in spinal cord function (to better or worse) were found in the current series after indirect spinal cord decompression through a posterior approach in patients with mild or no neurologic deficits. Further studies with larger series of patients presenting severe neurologic deficits are necessary to better establish these findings.
-
A retrospective study of microsurgical treatment of intramedullary spinal cord tumors (IMSCT) was conducted. ⋯ Most intramedullary spinal cord tumors need operative treatment as early as possible. The outcome of aggressive surgery now is much better than it has been in the past, and the results are acceptable. For malignant tumors and those where total removal has not been possible radiation therapy is necessary.
-
Retrospective review and multivariate analysis. ⋯ Together with our data, DHI and sROM showed a significant correlation with the incidence of recurrent lumbar disc herniation, suggesting that preoperative biomechanical conditions of the spine can be an important pathogenic factor in the site of lumbar disc surgery.
-
A retrospective review. ⋯ Dural ossification is a common finding in OLF. There are 2 radiologic signs of dural ossification, namely, the "tram track sign" and the "comma sign." Preoperative identification of dural ossification might help the surgeon to anticipate and appropriately deal with dural laceration during surgery. This will also help to counsel patients regarding the risks of surgery for OLF. The surgical and prognostic implications of dural ossification are being discussed.
-
Review Case Reports
Primary NK/T-cell lymphoma of the cauda equina: a case report and literature review.
A case report with a review of the literature. ⋯ Although primary lymphoma of the cauda equina is extremely rare, the prognosis of this condition is thought to be poor. Early definitive diagnosis with examination of the cerebrospinal fluid followed by combined treatment with radiotherapy and high-dose methotrexate should be considered.